Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends
Meticulous Research®—a leading global market research
company, published a research report titled Immunohistochemistry
(IHC) Market Size, Share, Forecast, & Trends Analysis by Offering
(Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining,
Imaging], Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast
to 2031.
According to this latest publication from Meticulous
Research®, the global immunohistochemistry market is estimated to reach $4.08
billion by 2031 at a CAGR of 7.2% from 2024 to 2031. The growth of
this market can be attributed to various factors, such as the rising
prevalence of chronic diseases coupled with the increasing geriatric
population, increasing focus on rare diseases, rising awareness
regarding early disease diagnosis, increasing R&D expenditure,
growing demand for drug discovery & development, rising prevalence
of infectious diseases, and the rise in healthcare expenditure.
Furthermore, increasing inclination towards personalized
medicine, advancements in genomics and proteomics, and increasing automation
in immunohistochemistry are expected to offer growth opportunities.
However, stringent technical requirements, regulatory processes, and the
availability of alternative technology are major hindrances to the
market’s growth.
Key Players
The key players operating in the global immunohistochemistry
market are:
- F.
Hoffmann-La Roche Ltd (Switzerland)
- Danaher
Corporation (U.S.)
- Agilent
Technologies, Inc. (U.S.)
- Merck
KGaA (Germany)
- Bio-Rad
Laboratories, Inc. (U.S.)
- Eagle
Biosciences, Inc. (U.S.)
- Thermo
Fisher Scientific Inc. (U.S.)
- Cell
Signaling Technology, Inc. (U.S.)
- PerkinElmer,
Inc. (U.S.)
- Bio
SB Inc. (U.S.)
- Biocare
Medical, LLC. (U.S.)
- Bio-Genex
Laboratories (U.S.)
- CANDOR
Bioscience GmbH (Germany)
- Innovex
Biosciences Inc. (U.S.)
Immunohistochemistry Market: Future Outlook
The global immunohistochemistry market is segmented by
Offering, Method, Process, Application, End User, and Geography. This study
also evaluates industry competitors and analyzes the market at the global and
regional levels.
By Offering
The market is divided into:
- Consumables
(Reagents [Fixation Reagents, Antigen Retrieval, Buffers, Blocking
Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and
Counterstain], and Other Accessories)
- Equipment
(Staining System, Imaging Systems, Slide Scanners, and Tissue Microarrays)
- Services
& Software
In 2024, the consumables segment is expected to
account for the largest share of the immunohistochemistry market. This
segment's dominance is due to advancements in IHC consumables, the advantages
offered by IHC kits and reagents, such as reduced time between sample analysis
and results, improved access to advanced IHC solutions, and the recurring use
of consumables.
By Method
The methods analyzed include:
- Avidin-Biotin
Complex
- Polymer-Based
Immunohistochemistry
- Catalyzed
Signal Amplification (CSA)
- Fluorescyl-tyramide
Amplification
- Improved
Catalyzed Signal Amplification (iCSA)
- Multi-Staining
Immunohistochemistry
- Labeled
Streptavidin Biotin (LSAB)
- PAP
Method
In 2024, the avidin-biotin complex segment is
expected to dominate the market, attributed to its labeling with peroxidase,
high affinity for biotin, and resistivity to enzymatic reactions and pH
changes.
By Application
Applications include:
- Research
Applications (Drug Discovery, Agriculture & Animal Research, Other
Applications)
- Clinical
Applications (Reproductive Health, Oncology, Infectious Disease, Other
Clinical Applications)
In 2024, the clinical applications segment is
anticipated to hold the largest market share, driven by the increasing
prevalence of chronic diseases, growing awareness of early disease diagnosis,
and increasing affordability of advanced IHC solutions among hospitals and
diagnostic laboratories.
By End User
End users are categorized into:
- Pharmaceutical
& Biotechnology Companies
- Hospitals
& Diagnostic Laboratories
- Academic
Institutes & Research Centers
- Other
End Users
In 2024, the hospitals & diagnostic laboratories
segment is projected to lead the market, thanks to the expansion of public
and private hospitals, the rising number of healthcare facilities in emerging
countries, the availability of well-equipped systems, and the presence of
skilled professionals in these settings.
Geographic Review
This research report provides a comprehensive analysis of
the market in:
- North
America (U.S. and Canada)
- Europe
(Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
- Latin
America (Brazil, Mexico, Rest of Latin America)
- Middle
East & Africa
Among all regions, Asia-Pacific is expected to
register the highest CAGR during the forecast period. The region's growth is
attributed to the emerging healthcare landscape, rapid urbanization, the need
to manage the growing burden of infectious diseases, accelerated economic
growth, and increased investments in enhancing healthcare accessibility and
infrastructure.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967
Key Questions Answered in the Report
- Which
are the high-growth market segments based on offerings, method,
application, end user, and region/country?
- What
was the historical market size for immunohistochemistry globally?
- What
are the market forecasts and estimates for the period 2024–2031?
- What
are the major drivers, restraints, challenges, opportunities, and trends
in the immunohistochemistry market?
- Who
are the major players in the global immunohistochemistry market?
- What
is the competitive landscape like, and who are the market leaders in the
global immunohistochemistry market?
- What
are the recent developments in the global immunohistochemistry market?
- What
are the different strategies adopted by the major players in the global
immunohistochemistry market?
- What
are the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment